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ABSTRACT The prion protein has garnered considerable interest because of its involvement in prion disease as well as its
unresolved cellular function. The octarepeat region in the ﬂexible N-domain is capable of binding copper through multiple
coordinationmodes. Under conditions of low pHand lowCu21 concentration, the four octarepeats (ORs) cooperatively coordinate
a single copper ion. Based on the average structure of the PHGGandGWGQportions of a copper-free OR2model frommolecular
dynamics simulations, the starting structures of the OR4 complex could be constructed by assembling the repeating structure of
PHGG and GWGQ fragments. The resulting model contains a preformed site suitable for Cu21 coordination. Molecular dynamics
simulations of Cu21 bound to the assembled OR4model (Cu:OR4) reveal a close association of speciﬁc Trp andGly residues with
the Cu21 center. This low Cu21-occupancy form of prion protein is redox-active and can readily initiate cleavage of the OR region,
mediated by reactive oxygen species generated by Cu1. The OR region is known to be required for b-cleavage, as are the Trp
residueswithin theOR region. Theb-cleaved form of the prion protein accumulates in amyloid ﬁbrils. Hence, the close approach of
Trp and Gly residues to the Cu21 coordination site in the low Cu21-occupancy form of the OR region may signal an important
interaction for the initiation of prion disease.
INTRODUCTION
Prion diseases, or transmissible spongiform encephalopa-
thies, are a family of neurodegenerative diseases that occur in
humans and several animals. They may arise spontaneously
through inheritance, or may be acquired through alternative
routes such as the ingestion of prion-contaminated foodstuffs
(1). Much interest in the prion protein (PrP) has been gen-
erated from its central role in prion disease. However, to date,
the physiological function(s) of the cellular form of the
protein (PrPC) remain unclear. The PrPC was proposed to
function as a copper-buffering protein (2,3), and to play a role
in neuronal development (4), neuroprotection (2,4,6,7), and
possibly memory (8).
The octarepeat (OR) region is located in the ﬂexible
disordered N-domain of human PrP, and consists of four
tandem repeats containing the sequence PHGGGWGQ (Fig.
1). Spontaneous and inherited gene mutations that give rise to
additional copies of the OR sequence in PrP were implicated
as risk factors for Creutzfeldt-Jakob disease (9,10). Mice
expressing an OR-deletion form of PrP demonstrated delayed
prion-disease onset and altered disease pathology after ex-
posure to infectious prion material (11). The OR region can
selectively bind Cu21 (12) through as many as three dis-
similar coordination modes, depending on the pH and/or
local Cu21 concentration, corresponding to high-occupancy,
intermediate-occupancy, or low-occupancy forms (13). In
addition, His-96, His-111, and the N-terminal amine in the
full-length N-domain can also contribute to Cu21 coordination
in the full-length protein (14). Under low Cu21-occupancy
conditions, copper coordination to the full-length N-terminal
domain results in multiple His-bound isomeric forms, pri-
marily involving the OR region and His-96 (15). The Cu21
binding to isolated fragments of the OR region was studied
extensively, using spectroscopic methods (16–18). Multiple
forms of copper (II) coordination occur throughout the disor-
dered N-terminal region of the PrP at pH 7.4. However, there is
limited information regarding the protein’s three-dimensional
(3D) structure after Cu21 binding to the OR region. A small-
molecule crystal structure of Cu21 bound to the HGGGW
residues of a single repeat was described (19), and is indicative
of the binding mode of the OR region under conditions of high
copper occupancy. This binding mode was recently used in
extended molecular-dynamics (MD) simulations to predict
how the OR region folds in response to high Cu21 occupancy
(7). Models were also proposed for the intermediate form of
Cu21 binding, based on spectroscopic data, mostly from
electron paramagnetic resonance, circular dichroism, and
nuclear magnetic resonance (NMR) spectroscopy (13,18).
Electron paramagnetic resonance reveals that Cu21 is bound
by several imidazole N-donor ligands in the low-occupancy
form, and its spectroscopic ﬁngerprint is indistinguishable
from that of Cu21 in the presence of 50-M excess imidazole
(13), indicating that the His imidazole side chains from each
repeat are the primary ligands involved in coordination. Un-
der low copper occupancy conditions, the metal center was
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shown to be redox-active, giving rise to the formation of re-
active oxygen species (ROS) and ROS-mediated cleavage of
PrPC (20–22). The cleavage site, termedb-cleavage, is around
Gly-90, near the end of the OR region.
Normal proteolytic processing of membrane-anchored
PrPC occurs through cleavage at position 111/112, termed
a-cleavage (18), which leaves PrP(112–231) anchored to the
cell surface. However, in prion-diseased brains, longer PrP
fragments accumulate in amyloid ﬁbrils comprised of
PrP(;90–231), with some variability in the site of cleavage
(18). The OR region is necessary for ROS formation, and
an OR-deletion form of PrP results in a loss of b-cleavage
and increased sensitivity to oxidative stress (23). Loss of
b-cleavage was linked to a loss of function of PrPC (6), and
may therefore be an important component in a protective
mechanism for clearing oxidants in the extracellular neu-
ronal environment. Two disease-associated PrP mutations
failed to undergo b-cleavage, and PrP/ cells, as well as
cells expressing PrP without the OR region, are more sus-
ceptible to oxidative stress (22). Without this protective
capacity, PrP is susceptible to oxidative modiﬁcation (oxi-
dative damage is also a hallmark of prion disease), and such
alterations increase the protein’s propensity to aggregate
(24,25).
In determining how Cu21-mediated ROS formation and
subsequent b-cleavage may occur, molecular modeling rep-
resents a necessary ﬁrst step, because the inherent ﬂexibility
of this portion of the PrP and the paramagnetic properties
of Cu21 make it difﬁcult to apply conventional structure-
determination methods such as x-ray crystallography or
NMR spectroscopy methods. Predicting the folded structure
of a protein a priori is problematic. The backbone of each
amino acid in a protein may have at least two stable confor-
mations, and to predict how n-residues could fold together
would require sampling as many as 2n conformations. For the
OR region of human PrP, this would involve a minimum of
232 (;4.3 billion) conformations. The method we use here
for generating a starting structure of the globular form of the
metal-free OR4 region follows an approach that resembles the
zipping-and-assembly procedure of Ozkan et al. (26), where
the average structure of a smaller metal-free fragment, as
previously described (7), is used to assemble a starting con-
formation of the full-length OR region. The repetitive nature
of the OR region (Fig. 1) makes it particularly amenable to
such an approach.
Computational procedure
Assembly of OR4 model
The full-length OR4 model includes the GGWGQ portion
of the non-Cu21-binding sequence that precedes the four
ORs in human PrP. Previous metal-free OR2 simulations (7)
showed a preference for the formation of a well-deﬁned bend
in the GWGQ region of the OR region, whereas the PHGG
portion of the sequences formed ﬂexible loops (Fig. 2). Based
on apo-OR2 simulations, the average f and c angles for each
residue in the PHGG loop and GWGQ bend were used to
construct an average structure for the full-length OR region
(Fig. 2).
Cu21 binding site
Each of the four His side chains in the assembled model is
closely packed and already suitably clustered together to
accommodate coordination of a metal ion. The His x1 and
x2 angles were modiﬁed to produce suitable starting struc-
tures for Cu21 coordination, where either all Nd1-atoms or
Ne2-atoms were oriented toward a common center for in-
sertion of a Cu21 atom. In the copper-free OR2 simulations,
close association between His side chains was also evident,
as shown in Fig. S7 in Supplementary Material, Data S1.
Density functional theory modeling and derivation of DG(aq)
calc
Small-molecule structure models of the His side chain were
modeled as 4-methylimidazole, in two alternate protonation
FIGURE 1 Sequences of OR4 and OR2 peptide models, compared with a
portion of human PrP sequence.
FIGURE 2 Stable structures of PHGG and GWGQ por-
tions of a single octarepeat (OR) were derived from two
130-ns metal-free OR2 MD simulations and used to assem-
ble the Cu:OR4 model. RMS-ﬁtted overlays of PHGG and
GWGQ portions of the OR2 model are shown in two
orientations. Loops and turns of the PHGG and GWGQ
regions are emphasized. The PHGG and GWGQ residues in
a representative OR of the assembled Cu:OR4 model are
highlighted. The remaining His residues and the copper
center in the Cu:OR4 model are shown for clarity.
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states or Cu21-bound states (Fig. 3). The Cu21 complexes
were modeled as [CuII(4-methylimidazole)(OH2)3]
21. All
density functional calculations were performed with the
Gaussian 03 suite of software (27). Geometry optimizations
were performed at the B3LYP/6-31G(d) level, until the
difference in energy between subsequent optimization steps
was below 0.03 kJ mol1. This step also included harmonic-
frequency calculations, from which zero-point vibrational
energies, temperature-dependent enthalpy corrections, and
entropies were derived. Single-point energy calculations
from B3LYP/6-31G(d) structures were computed, using a
larger basis set to obtain more accurate relative energies
between structures (B3LYP/6-3111G(2df,2p)). Solvation
was taken into account using a polarizable continuum
model, IEFPCM (28–30), with the radius for Cu21 as 1.40
A˚, and the dielectric constant set at 78.39 (water).
The aqueous free-energy change (DGcalcðaqÞ) is calculated as:
DG
calc
ðaqÞ ¼ DHðgÞ  TDSðgÞ1DDGðsolvÞ;
where DH(g) and DS(g) are the energy and entropy difference
between product and reactant enthalpies, DH(g) is corrected
to 298 K and includes the zero-point energy, and DS(g) is the
entropy difference between species, as provided in the fre-
quency-calculation output. The DDG(solv) term is the differ-
ence between the free energy of solvation (DG(solv)) for the
product and reactant species.
Initial Cu21-bound OR4 geometry setup
Short-duration simulations were run with a single Cu21-atom
bound through either the Nd1-atoms or Ne2-atoms of all four
His residues. These initial models contained Cu21 close to
the desired His N-donor atoms, and were energy-minimized
by steepest descent in the absence of solvent molecules,
using GROMACS (31,32) and the OPLS all-atom force ﬁeld
(33,34). After energy minimization, the Cu1:OR4 models
were simulated for 100 ps to relax the Cu21-binding region.
This procedure generated structures that could be subse-
quently simulated in the presence of solvent.
MD simulation
After the generation of the starting geometries, each molecule
was placed in a 4.53 4.53 4.5 nm box, surrounded by 2836
SPC solvent molecules (35,36). Two Cl counterions were
also added, to maintain the charge neutrality of the copper-
containing system. Each of the systems was energy-minimized
in the presence of explicit solvent, and simulated for 200 ns at
300 K, with an initial 5-ns equilibration phase. Simulations
were subsequently performed according to previously de-
scribed methods (7).
Parameterization of Cu21 binding models
Alternate Nd1-bound and Ne2-bound [CuII(4-methyl-
imidazole)4]
21 models were geometry optimized at the
B3LYP/6-31G(d) level, until the difference in energy be-
tween subsequent optimization steps was below 0.03 kJ
mol1. The geometry-optimization step was followed by a
harmonic-frequency calculation at the same level of theory,
to ensure that geometries were at a stationary point on the
potential energy surface, and to derive force constants for
Cu-ligand bonds.
The CHelpG charges (37) were calculated for each of the
structures at the B3LYP/6-31G(d) level. Calculated parame-
ters were imported into the OPLS all-atom force ﬁeld, fol-
lowing previously described methods (7). The CHelpG
charges for the copper centers in each of the [CuII(4-methyl-
imidazole)4]
21 models were averaged to 10.700. The back-
bone charges for His residues were maintained from the
OPLS force ﬁeld, whereas the imidazole ring and CbH2
fragments had a net charge of10.325 each, making the total
charge for the copper(His)4 binding sites 12.000. In the
Nd1-bound Cu:OR4 simulations, the Cu
21-N-donor atom
distanceswere all 1.985 A˚, averaged from the associatedNd1-
bound [CuII(4-methylimidazole)4]
21 models, and the force
constants for each of the Cu-N bonds were 45,082 kJ mol1
nm2. The Ne2-bound Cu:OR4 simulations used a Cu
21-N-
donor atom distance of 1.914 A˚, with force constants of
46,346 kJ mol1 nm2. The Cu21 centers were in a pseu-
dosquare planar geometry, based on the coordination geom-
etries of the calculated [CuII(4-methylimidazole)4]
21models,
and were of pseudo-D2d symmetry. The parameters for re-
straining the coordination geometries inMD simulations used
improper dihedral force constants of 33.472 kJ mol1 rad2.
RESULTS
Generation of starting conformation
of OR4 model
Using the results of previously described MD simulations (7)
as well as additional simulations containing modiﬁed force-
FIGURE 3 Tautomeric forms of His side chain, modeled as 4-methyl-
imidazole. Theory and experiment both predict the Ne2-position as the
favored site for protonation. Alternate sites of Cu21 coordination are
compared, and modeled as [CuII(4-methylimidazole)(OH2)3]
21 (coordinat-
ing solvent not depicted). Relative free energies are in kJ mol1.
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ﬁeld parameters for tryptophan, a total of 300 ns of simula-
tion time was generated for the copper-free OR2 model (Fig.
1). Cluster analysis was used to group each of the visited
conformations with similar conformations from all simula-
tions, based on a root mean-square deviation (RMSD) cutoff
of 0.1 nm, and included all residues in the OR2 model. The
PHGG and GWGQ residues from the major cluster of each
simulation, corresponding to the most populated conforma-
tion shown in Fig. 2, were then used to generate average f
and c angles for each residue.
The mean f and c angles were input for each series of
PHGG and GWGQ residues in the OR4 model. The assem-
bled structure (Fig. 2) contains no other overlapping atoms or
side-chain clashes, aside from initially overlapping His im-
idazole rings (not shown). The His side chains in the OR2
models were also seen to make prolonged close approaches
to one another (Fig. S7 in Data S1). The close packing of His
side chains in the assembled model present a preformed site
suitable for coordination of a single Cu21 atom. The His side-
chain x1 and x2 angles were subsequently modiﬁed, so that
either the Nd1-atoms or Ne2-atoms were suitably oriented to
coordinate a central Cu21 atom, as depicted in Fig. 2.
Histidine side-chain tautomers and Cu21
coordination sites
The His side chain contains two N-atoms that confer the
imidazole ring with multiple protonation states, and at
physiological pH, two tautomeric forms of the charge-neutral
imidazole ring may exist, as shown in Fig. 3. These tauto-
meric forms differ in the site of protonatation, at either the
Nd1-atom or Ne2-atom. Experimentally, a slight preference
was found for protonation at the Ne2 position of the imida-
zole ring at physiological pH, meaning that the Nd1-atom is
most likely to bear the lone electron pair (38–40). The cal-
culated aqueous free-energy difference (DGcalcðaqÞ) for the two
tautomeric forms of His, modeled as 4-methylimidazole,
is 1.9 kJ mol1, slightly favoring protonation at the Ne2-
atom position. This agrees with the experimentally observed
equilibrium for His (38,39). The real DG(aq) for the amino
acid has further contributions fromH-bonds that stabilize this
tautomer through the Nd1-atom lone pair and adjacent
backbone amide protons (39,41).
The DGcalcðaqÞ between the two tautomeric forms for the site
of copper coordination, at either the Nd1-atom or Ne2-atom
position, modeled as [CuII(4-methylimidazole)(OH2)3]
21,
reveals that the Ne2-bound form is 3.0 kJ mol1 more stable
than the Nd1-bound form (Fig. 3). This indicates that coor-
dination through the e N-atom is likely. Miura et al. observed
that at pH ;6.5, the OR4 region binds Cu
21 via the Ne2-
atoms, whereas at lower pH, the His side chains protonate,
making them unavailable for coordination, and as pH is
increased, coordination via the Nd1-atoms is ultimately
preferred (42). Thus, coordination of Cu21 via the Ne2-atom
site appears to be preferred. However, the small free-energy
difference for Cu21 coordination, as shown in Fig. 3, led us to
model two alternate coordination modes for the Cu21:OR4
model, with His coordination through either four Nd1-atoms
or four Ne2-atoms concurrently.
Average Cu21:OR4 structures
No stable helical or b-sheet structures formed during MD
simulations of the assembled structures, in agreement with
the lack of secondary structure evidenced by circular di-
chroism spectroscopy (43,44). Comparing results from the
Nd1-bound and Ne2-bound Cu21:OR4 models, coordination
by all four Nd1-atoms of the His residues maintains a more
compact globular form of the OR4 region, whereas Ne2-co-
ordination tends to fan each OR loop outward (Fig. 4) during
a simulation. The Nd1-bound form also sequesters the metal
center more than does the Ne2-bound form, which maintains
a solvent-exposed metal-binding site (Fig. 4). The RMS-
ﬁtted overlays from the ﬁnal 20 ns of the (PHGGGWGQ)3PH
portions of each Cu21:OR4 model, as well as each individual
repeat (numbered OR1 through OR4) from each simulation,
are shown in Fig. 4. Once anchored to the Cu21 center
through the His side chains, each repeat deviates little from its
initial average conformation. The N-terminal and C-terminal
ends of the model comprise the preceding GGWGQ, and the
terminating GWGQ residues are disordered and display
greater ﬂexibility than the remaining OR4 regions in the
course of simulations. Additional RMSD data are presented
in Fig. S8 in Data S1.
Tryptophan and glycine residues in the OR
region can interact with bound Cu21
The peptide backbone of much of the Nd1-bound and Ne2-
bound models is held away from the metal center because of
coordination via the His imidazole side chains. This makes
interactions between other portions of the OR region with the
metal coordination site less likely. In the Nd1-bound Cu:OR4
system (Fig. 4), although the metal center is somewhat se-
questered from access by solvent, a portion of the fourth
repeat can come into close contact with the Cu21 ion,
whereas in the Ne2-bound form, a portion of the fourth repeat
as well as the third repeat can both make transient close ap-
proaches to the metal coordination site.
The Trp residues, located at the turns in the OR loops
between the successive Cu21-binding His residues, are al-
ways solvent-exposed during simulations. On average, the
Trp-Cu21 internuclear separation (measured between the Trp
indole Ne1-atom and Cu21) for all Trp residues in both the
Ne2-bound and Nd1-bound simulations is 10 A˚ or greater.
Speciﬁc Trp residues in each simulation, however, demon-
strate signiﬁcantly closer approaches to the metal center, such
as the Trp residue from the third repeat in the Ne2-bound
model and the Trp residue from the fourth repeat in the Nd1-
bound model. In these instances, the Trp-Cu21 separation
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may be as low as 6–7 A˚ (Fig. 5 A). A summary of all Trp Ne1-
Cu21 internuclear separations from each simulation are
presented in Fig. S9 in Data S1.
Applicability of Cu:OR4 models
The procedure of constructing copper-binding OR4 models
through assembly has some speciﬁc assumptions associated
with it. Firstly, the assembled OR4 structure assumes that all
four OR regions will cooperatively fold in the same manner
as they do in the copper-free OR2models fromwhich they are
derived. Secondly, coordination by all four His residues
concurrently does not allow for additional conformational
ﬂexibility within the OR region. Each of these points is ad-
dressed below.
Previous NMR experiments by Yoshida et al. (45) and
Zahn (46) revealed that the OR region adopts loop and turn-
type structures, which are also formed in our apo-OR2
models (7). These experimental observations lend indirect
support to the conformation of the preformed copper-coor-
dinating structure that we established through the assembly
of OR fragments.
The ability of His ligands to become labile and exit the
coordination sphere would not only allow those regions of
the backbone greater ﬂexibility, but could also allow for
further variability in Cu21-coordination when the His imid-
azole reenters the coordination sphere, with the possibility
that an alternate imidazole N-donor atom may coordinate to
copper, or alternate backbone conformations may be acces-
sible. This type of exchange in the ligand environment could
in principle give rise to 16 alternate four-coordinate geome-
tries (42), and as many local potential energy surfaces to
explore. Further consideration of intermediate coordination
geometries, e.g., by only three His residues, could further
increase the complexity and number of possible models.
Taking these considerations into account, the models
presented here comprise the most tractable initial approach
to understanding the low-Cu21-occupancy form of the OR
region. The Cu21 coordination via Ne2-atoms of the His
residues in the Cu1OR4 model is in agreement with the pre-
viously observed coordination mode of the OR4 peptide at
pH 6.5 by Raman spectroscopy (42).
DISCUSSION
The Trp residues within the OR region were shown to be
necessary for the redox competence of the low-occupancy form
of Cu21 bound to the OR region of PrP (47), whereas succes-
sivebinding ofCu21 renders themetal ions redox-inactive. The
consequence of Cu21 binding in the low-occupancy, redox-
active form is ROS formation and subsequent b-cleavage of
the OR region from the remainder of membrane-anchored
PrPC. The Trp residues may act as one-electron donors, facil-
itating reduction of the single Cu21 center to Cu1, within the
OR region. Our MD simulations implicate a close association
between the boundCu21 atom and speciﬁc Trp residueswithin
the OR region.
The only Trp residues from either series of simulations
to make a signiﬁcantly close approach to the Cu21 ion are
Trp-80 and Trp-89. However, other Trp residues may occa-
sionally come to within 10 A˚ as well. A previous model from
Miura et al. indicated that Trp-65 and Trp-73 could interact
with Cu21 (42). Because their model was derived by only
constraining the coordinating His residues to remain bound to
the Cu21 center, without accounting for the folding preference
FIGURE 4 The Nd1- and Ne2-bound complexes (A and B, respectively)
were each simulated for 200 ns. Overlays of 2000 structures from the ﬁnal 20 ns
of each simulation, shown in two orientations, are RMS-ﬁtted, using
(PHGGGWGQ)3PH backbone heavy atoms. The major conformation of each
octarepeat is shown, with Cu21-binding His and GWGQ residues explicitly
drawn. Numbering from the human PrP sequence is shown.
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of the sequence, we are inclined to assert that Trp-80 and Trp-
89 (from the two C-terminal repeats) are important for
b-cleavage. These observations beg the question of whether
such interactionsmay play a role in the ability of the OR region
to reduce Cu21 to Cu1 during ROS formation. In addition to
Cu21 coordination, the four-His coordination environment of
the OR region is also compatible with Cu1 binding. The OR4
region is sufﬁciently ﬂexible to accommodate the tetrahedral
coordination geometry required for stabilizing Cu1 formation.
As noted earlier, the assembled OR4 models can accom-
modate tetrahedral coordination geometry, and are not only
compatible with Cu1 binding, but with Zn21 coordination as
well (data not shown). Copper and zinc binding to the
N-terminal domain triggers endocytosis of PrP (48), and
these models offer further structural details that may be used
to reﬁne structure interactions with neighboring regions of
PrP and micelle environments (49), as well as offer insights
into the initial events leading to b-cleavage. The structures
presented here may provide the ﬁrst clues that relate Cu21
binding, ROS formation, and the site speciﬁcity ofb-cleavage.
Because b-cleavage is the result of ROS formation, it is
likely that the site at which reactive species are formed is at,
or near, the site of cleavage. Generation of ROS at a more
remote site would require the formation of diffusible ROS
that would ultimately result in less site-speciﬁc cleavage,
indicating that the site of ROS formation likely involves the
initial close approach of the protein backbone to the metal
center. Several repeats in each of the series of simulations
make such an approach to the metal center, and both the Ca-
atoms of Trp (residue 89) and Gly (residue 90) make transient
approaches to within ,6 A˚ of the Cu21 center in the Nd1-
bound simulation, as shown in Fig. 5 B. Similar interaction
with other repeats in alternate conformations may provide a
structural mechanism for ROS-mediated b-cleavage within
the OR region.
Our proposed mechanism for copper-mediated ROS for-
mation, shown in Fig. 6, is initiated by close association of
Trp with the Cu21 center, followed by subsequent electron
transfer from the Trp indole to form Cu1. In the presence of
H2O2, Cu
1 is readily oxidized back to Cu21, and results in
the formation of HO and HO. Hydroxyl radicals are highly
reactive, and are likely to react at or near their site of for-
mation: in this instance, through H-atom abstraction from a
nearby aliphatic group. Because of the high abundance of
Gly residues in the OR region (Fig. 1), the local protein
backbone contains multiple potential targets for H-atom ab-
straction. Hydroxyl radical damage at a Gly residue results in
a C-centered radical, and the subsequent reaction of Gly(Ca)
with O2 triggers C-N or C-C backbone cleavage within the
FIGURE 5 Snapshots of the close approach of Trp res-
idues to the Cu21-binding site in (A) Ne2-bound and (B)
Nd1-bound models from MD simulations. Each of the His
and Trp side chains is drawn for clarity. Nterm and Cterm
denote the N-terminal and C-terminal ends of the sequence,
respectively.
FIGURE 6 Mechanism of copper-mediated hydroxyl radical formation
and subsequent b-cleavage of protein backbone. Copper coordination
environments for Cu21 and Cu1 are depicted as their preferred square
planar and tetrahedral geometry respectively, both of which can be accom-
modated by the ﬂexible octarepeat region of PrP.
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damaged residue. The most likely Gly residues to be targets
of HO attack would be those closest to the Cu21 center. The
close approach of Trp-89 and each of its adjacent Gly resi-
dues, as observed in these simulations, lends support for their
proximity to this potential ROS-generating site. The formed
Trp indole radical cation (Trp1) may undergo subsequent
reactions, including deprotonation at the indole N(H) site, as
well as cross-linking reactions with other Trp1 residues. It
may also be possible that Trp1 plays a role in directing
b-cleavage of the local protein backbone. However, further
work would be necessary to establish a mechanistic link.
Previous experiments (50) suggested that copper-binding
to PrP can induce a proteinase-resistant form of PrP, possibly
through folding in the N-domain. Although it is clear that the
OR region can become structured in response to increasing
copper loads, recent evidence indicates that copper itself in-
hibits proteinase-K, and therefore cannot be used to infer the
presence of speciﬁc structuring within PrP in this manner
(51).
These structures provide the ﬁrst account of the con-
formation of the OR region under conditions of low-Cu21-
occupancy in mammalian PrP. The OR region was recently
shown to bind Zn21 in a manner similar to that of Cu21 (52),
and these structures are also compatible with Zn21 coordi-
nation. These results are a necessary ﬁrst step toward more
elaborate structural models for Cu21-binding to this region of
PrP, and toward understanding the associated redox activity
of PrP-bound copper and their relationship to prion disease.
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